Literature DB >> 24386017

Deep vein thrombosis in patients with severe motor and intellectual disabilities.

Hiromitsu Ohmori1, Fumihiro Ochi2, Naoyuki Tanuma3, Eiichi Ohnuki4, Masami Yamasaki4, Hiroko Takesue5, Miki Kan6, Nobuo Matsumoto7, Ryo Sumimoto8, Akira Harada4.   

Abstract

Most patients with severe motor and intellectual disabilities (SMID) have restricted mobility capability and have been bedridden for long periods because of paralysis of the extremities caused by abnormal muscular tonicity due to cerebral palsy and developmental disabilities, and such patients are associated with a high risk for the complications of deep vein thrombosis (DVT). Here, we report 8 patients (34.8%) with DVT among 23 patients with SMID during prolonged bed rest. However, we did not detect thrombosis in the soleal veins, finding it mostly in the superficial femoral and common femoral veins. Regarding laboratory data for the coagulation system, there were no cases with D-dimer above 5 µg/ml. Concerning sudden death in patients with SMID, we have to be very careful of the possibility of pulmonary thromboembolism due to DVT. Therefore, we should consider the particularities of an underdeveloped vascular system from underlying diseases for the evaluation of DVT in patients with SMID. A detailed study of DVT as a vascular complication is very important for smooth medical care of SMID and compression Doppler ultrasonography of the lower extremities, as noninvasive examination, is very helpful. (English translation of Jpn J Phlebol 2012; 23: 17-24).

Entities:  

Keywords:  deep vein thrombosis (DVT); pulmonary thromboembolism; severe motor and intellectual disabilities (SMID); ultrasonography

Year:  2013        PMID: 24386017      PMCID: PMC3866357          DOI: 10.3400/avd.oa.13-00090

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  16 in total

1.  D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.

Authors:  Mojca Bozic; Ales Blinc; Mojca Stegnar
Journal:  Thromb Res       Date:  2002-11-01       Impact factor: 3.944

2.  The origin of lower extremity deep vein thrombi in acute venous thrombosis.

Authors:  S L Hill; G I Holtzman; D Martin; P Evans; W Toler; K Goad
Journal:  Am J Surg       Date:  1997-06       Impact factor: 2.565

3.  Maldevelopments of the vascular system: clinical conundrums.

Authors:  A E Young
Journal:  Ciba Found Symp       Date:  1983

Review 4.  Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.

Authors:  A A Timur; D J Driscoll; Q Wang
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

Review 5.  Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: a review.

Authors:  Adriana Lee; David Driscoll; Peter Gloviczki; Ricky Clay; William Shaughnessy; Anthony Stans
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

6.  Epidemiological characteristics of acute pulmonary thromboembolism in Japan.

Authors:  N Yamada; M Nakamura; K Ishikura; M Ota; T Yazu; N Hiraoka; H Tanaka; M Ito; H Fujioka; N Isaka; T Nakano
Journal:  Int Angiol       Date:  2003-03       Impact factor: 2.789

7.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review.

Authors:  Paul D Stein; Russell D Hull; Kalpesh C Patel; Ronald E Olson; William A Ghali; Rollin Brant; Rita K Biel; Vinay Bharadia; Neeraj K Kalra
Journal:  Ann Intern Med       Date:  2004-04-20       Impact factor: 25.391

9.  [A clinical study of sudden death in the severely handicapped persons].

Authors:  R Yoshida; A Ishizaki; J Sato; Y Fukuyama
Journal:  No To Hattatsu       Date:  1995-11

10.  Pulmonary embolism in patients with isolated soleal vein thrombosis.

Authors:  S Ohgi; M Tachibana; M Ikebuchi; Y Kanaoka; T Maeda; T Mori
Journal:  Angiology       Date:  1998-09       Impact factor: 3.619

View more
  5 in total

1.  Evaluation of D-Dimer in Screening Deep Vein Thrombosis in Hospitalized Japanese Patients with Acute Medical Diseases/Episodes.

Authors:  Hiroshi Matsuo; Yoshie Nakajima; Tomohiro Ogawa; Makoto Mo; Junichi Tazaki; Takahiro Doi; Norikazu Yamada; Takeo Suzuki; Hiromu Nakajima
Journal:  Ann Vasc Dis       Date:  2016-07-19

2.  Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients.

Authors:  Norikazu Yamada; Kazuhiko Hanzawa; Satoshi Ota; Mashio Nakamura; Koichi Sato; Maiko Ikura; Takeo Suzuki; Toshihiko Kaise; Hiromu Nakajima; Masaaki Ito
Journal:  Ann Vasc Dis       Date:  2015-06-19

3.  Contraceptive Practices and Reproductive Health Considerations for Adolescent and Adult Women with Intellectual and Developmental Disabilities: A Review of the Literature.

Authors:  Jorge V Verlenden; Jeanne Bertolli; Lee Warner
Journal:  Sex Disabil       Date:  2019-10

4.  Preoperative deep vein thrombosis in patients with cervical spondylotic myelopathy scheduled for spinal surgery.

Authors:  Le Liu; Yan-Bin Liu; Jian-Min Sun; Hai-Feng Hou; Chen Liang; Tao Li; Heng-Tao Qi
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

5.  Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus Edoxaban.

Authors:  Hiromitsu Ohmori; Akiko Kada; Mashio Nakamura; Akiko M Saito; Yoshitami Sanayama; Tomoe Shinagawa; Hiroshi Fujita; Akiko Wakisaka; Keiko Maruhashi; Akiko Mizukami; Noboru Takizawa; Hiroaki Murata; Michiko Inoue; Hideo Kaneko; Hidekazu Taniguchi; Nozomi Sano; Naoyuki Tanuma; Masao Kumode; Tomoki Takechi; Yukihiro Koretsune; Ryo Sumimoto; Takeshi Miyanomae
Journal:  Ann Vasc Dis       Date:  2019-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.